QuidelOrtho ROE 2012-2025 | QDEL
Current and historical return on equity (ROE) values for QuidelOrtho (QDEL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| QuidelOrtho ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-1.18B | $2.04B | -43.62% |
| 2025-06-30 | $-0.47B | $2.79B | -15.58% |
| 2025-03-31 | $-0.36B | $3.00B | -11.63% |
| 2024-12-31 | $-2.05B | $2.99B | -64.86% |
| 2024-09-30 | $-1.87B | $3.19B | -50.89% |
| 2024-06-30 | $-1.86B | $3.17B | -45.21% |
| 2024-03-31 | $-1.77B | $3.31B | -38.61% |
| 2023-12-31 | $-0.01B | $5.01B | -0.20% |
| 2023-09-30 | $0.01B | $4.97B | 0.26% |
| 2023-06-30 | $0.05B | $5.00B | 0.91% |
| 2023-03-31 | $0.12B | $5.00B | 2.38% |
| 2022-12-31 | $0.55B | $4.94B | 12.85% |
| 2022-09-30 | $0.81B | $4.80B | 23.02% |
| 2022-06-30 | $1.01B | $4.92B | 36.92% |
| 2022-03-31 | $1.01B | $2.42B | 54.46% |
| 2021-12-31 | $0.70B | $1.93B | 43.56% |
| 2021-09-30 | $0.88B | $1.63B | 60.19% |
| 2021-06-30 | $0.90B | $1.41B | 70.75% |
| 2021-03-31 | $0.95B | $1.49B | 88.52% |
| 2020-12-31 | $0.81B | $1.33B | 95.32% |
| 2020-09-30 | $0.37B | $0.85B | 56.51% |
| 2020-06-30 | $0.16B | $0.61B | 26.83% |
| 2020-03-31 | $0.09B | $0.61B | 15.93% |
| 2019-12-31 | $0.07B | $0.56B | 14.14% |
| 2019-09-30 | $0.07B | $0.53B | 15.33% |
| 2019-06-30 | $0.07B | $0.51B | 15.46% |
| 2019-03-31 | $0.07B | $0.46B | 15.82% |
| 2018-12-31 | $0.07B | $0.43B | 19.55% |
| 2018-09-30 | $0.04B | $0.39B | 11.25% |
| 2018-06-30 | $0.02B | $0.37B | 6.98% |
| 2018-03-31 | $0.01B | $0.33B | 4.44% |
| 2017-12-31 | $-0.01B | $0.23B | -4.10% |
| 2017-09-30 | $-0.01B | $0.22B | -2.81% |
| 2017-06-30 | $0.00B | $0.21B | -0.48% |
| 2017-03-31 | $0.00B | $0.22B | 1.48% |
| 2016-12-31 | $-0.01B | $0.20B | -7.10% |
| 2016-09-30 | $-0.01B | $0.20B | -5.95% |
| 2016-06-30 | $-0.01B | $0.19B | -5.79% |
| 2016-03-31 | $-0.01B | $0.20B | -6.00% |
| 2015-12-31 | $-0.01B | $0.22B | -2.61% |
| 2015-09-30 | $0.00B | $0.22B | 0.42% |
| 2015-06-30 | $0.00B | $0.23B | -1.70% |
| 2015-03-31 | $0.00B | $0.25B | -0.86% |
| 2014-12-31 | $-0.01B | $0.25B | -3.53% |
| 2014-09-30 | $-0.01B | $0.22B | -6.32% |
| 2014-06-30 | $-0.01B | $0.22B | -5.41% |
| 2014-03-31 | $-0.01B | $0.23B | -3.16% |
| 2013-12-31 | $0.01B | $0.22B | 3.19% |
| 2013-09-30 | $0.02B | $0.22B | 7.02% |
| 2013-06-30 | $0.02B | $0.22B | 8.74% |
| 2013-03-31 | $0.02B | $0.22B | 8.62% |
| 2012-12-31 | $0.01B | $0.20B | 2.65% |
| 2012-09-30 | $0.00B | $0.19B | -1.62% |
| 2012-06-30 | $0.00B | $0.18B | -1.63% |
| 2012-03-31 | $0.00B | $0.19B | -2.18% |
| 2011-12-31 | $0.01B | $0.19B | 3.83% |
| 2011-09-30 | $0.01B | $0.18B | 3.64% |
| 2011-06-30 | $0.00B | $0.18B | 0.68% |
| 2011-03-31 | $0.00B | $0.18B | 2.29% |
| 2010-12-31 | $-0.01B | $0.11B | -9.54% |
| 2010-09-30 | $0.01B | $0.11B | 7.59% |
| 2010-06-30 | $0.03B | $0.12B | 24.95% |
| 2010-03-31 | $0.03B | $0.12B | 28.39% |
| 2009-12-31 | $0.03B | $0.13B | 29.27% |
| 2009-09-30 | $0.02B | $0.12B | 17.12% |
| 2009-06-30 | $0.01B | $0.10B | 7.98% |
| 2009-03-31 | $0.01B | $0.11B | 6.05% |
| 2008-12-31 | $0.02B | $0.12B | 16.27% |
| 2008-09-30 | $0.02B | $0.13B | 18.42% |
| 2008-06-30 | $0.02B | $0.11B | 16.78% |
| 2008-03-31 | $0.02B | $0.11B | 16.59% |
| 2007-12-31 | $0.01B | $0.11B | 13.13% |
| 2007-09-30 | $0.02B | $0.10B | 23.53% |
| 2007-06-30 | $0.02B | $0.09B | 24.40% |
| 2007-03-31 | $0.02B | $0.10B | 22.64% |
| 2006-12-31 | $0.02B | $0.10B | 22.83% |
| 2006-09-30 | $0.01B | $0.08B | 14.77% |
| 2006-06-30 | $0.01B | $0.09B | 13.95% |
| 2006-03-31 | $0.01B | $0.09B | 16.97% |
| 2005-12-31 | $-0.01B | $0.09B | -11.65% |
| 2005-09-30 | $-0.02B | $0.08B | -25.64% |
| 2005-06-30 | $-0.03B | $0.07B | -30.67% |
| 2005-03-31 | $-0.03B | $0.07B | -28.90% |
| 2004-12-31 | $-0.01B | $0.09B | -7.61% |
| 2004-09-30 | $0.01B | $0.09B | 14.13% |
| 2004-06-30 | $0.02B | $0.09B | 19.83% |
| 2004-03-31 | $0.02B | $0.10B | 24.13% |
| 2003-12-31 | $0.02B | $0.09B | 29.47% |
| 2003-09-30 | $0.00B | $0.07B | 4.65% |
| 2003-06-30 | $0.00B | $0.07B | 3.14% |
| 2003-03-31 | $0.00B | $0.07B | 3.16% |
| 2002-12-31 | $0.00B | $0.06B | 1.60% |
| 2002-09-30 | $0.00B | $0.06B | 1.62% |
| 2002-06-30 | $0.00B | $0.06B | 3.29% |
| 2002-03-31 | $0.00B | $0.06B | 1.68% |
| 2001-12-31 | $0.00B | $0.06B | 0.00% |
| 2001-09-30 | $0.00B | $0.06B | -5.17% |
| 2001-06-30 | $-0.01B | $0.06B | -12.90% |
| 2001-03-31 | $-0.01B | $0.06B | -11.59% |
| 2000-12-31 | $-0.01B | $0.06B | -12.24% |
| 2000-09-30 | $0.00B | $0.04B | -8.79% |
| 2000-06-30 | $0.00B | $0.05B | -4.40% |
| 2000-03-31 | $0.00B | $0.05B | -4.47% |
| 1999-12-31 | $0.01B | $0.04B | 11.30% |
| 1999-09-30 | $0.01B | $0.04B | 14.12% |
| 1999-06-30 | $0.01B | $0.05B | 17.18% |
| 1999-03-31 | $0.01B | $0.05B | 18.06% |
| 1998-12-31 | $0.00B | $0.04B | 0.00% |
| 1998-09-30 | $0.00B | $0.04B | 2.72% |
| 1998-06-30 | $0.00B | $0.04B | 5.48% |
| 1998-03-31 | $0.00B | $0.04B | 2.80% |
| 1997-12-31 | $0.00B | $0.04B | 5.67% |
| 1997-09-30 | $0.00B | $0.04B | 6.02% |
| 1997-06-30 | $0.00B | $0.03B | 6.45% |
| 1997-03-31 | $0.00B | $0.04B | 10.34% |
| 1996-12-31 | $0.00B | $0.03B | 7.48% |
| 1996-09-30 | $0.00B | $0.03B | 0.00% |
| 1996-06-30 | $0.00B | $0.03B | 0.00% |
| 1996-03-31 | $0.00B | $0.03B | 0.00% |
| 1995-12-31 | $0.00B | $0.03B | -8.25% |
| 1995-09-30 | $0.00B | $0.02B | -4.30% |
| 1995-06-30 | $0.00B | $0.02B | -8.99% |
| 1995-03-31 | $0.00B | $0.02B | -18.60% |
| 1994-12-31 | $0.00B | $0.02B | -14.29% |
| 1994-09-30 | $0.00B | $0.02B | -18.60% |
| 1994-06-30 | $0.00B | $0.02B | -13.48% |
| 1994-03-31 | $0.00B | $0.02B | -10.00% |
| 1993-12-31 | $0.00B | $0.02B | 0.00% |
| 1993-09-30 | $0.00B | $0.02B | 0.00% |
| 1993-06-30 | $0.00B | $0.01B | 0.00% |
| 1993-03-31 | $0.00B | $0.01B | 9.76% |
| 1992-12-31 | $0.00B | $0.01B | 0.00% |
| 1992-09-30 | $0.00B | $0.01B | 0.00% |
| 1992-06-30 | $0.00B | $0.01B | 0.00% |
| 1992-03-31 | $0.00B | $0.01B | 0.00% |
| 1991-09-30 | $0.00B | $0.01B | 0.00% |
| 1991-06-30 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.223B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $210.647B | 24.28 |
| EssilorLuxottica (ESLOY) | France | $144.389B | 0.00 |
| Stryker (SYK) | United States | $137.523B | 27.31 |
| Boston Scientific (BSX) | United States | $135.199B | 30.92 |
| Medtronic (MDT) | Ireland | $126.407B | 17.51 |
| Medline (MDLN) | United States | $58.001B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.030B | 0.00 |
| Agilent Technologies (A) | United States | $38.508B | 24.34 |
| ResMed (RMD) | United States | $36.951B | 25.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.909B | 17.17 |
| Koninklijke Philips (PHG) | Netherlands | $27.434B | 17.92 |
| Insulet (PODD) | United States | $19.996B | 62.06 |
| Terumo (TRUMY) | Japan | $19.854B | 22.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.202B | 10.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.668B | 0.00 |
| Baxter (BAX) | United States | $9.962B | 8.04 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.437B | 30.34 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.369B | 13.31 |
| Envista Holdings (NVST) | United States | $4.002B | 22.96 |
| BillionToOne (BLLN) | United States | $3.934B | 0.00 |
| ICU Medical (ICUI) | United States | $3.783B | 24.02 |
| Haemonetics (HAE) | United States | $3.281B | 14.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.114B | 14.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Perrigo (PRGO) | Ireland | $2.077B | 5.20 |
| Neogen (NEOG) | United States | $2.034B | 44.52 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 39.18 |
| AtriCure (ATRC) | United States | $1.910B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.683B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Green Thumb Industries (GTBIF) | United States | $1.620B | 71.00 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.398B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.342B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.192B | 353.71 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.019B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.874B | 9.87 |
| Omeros (OMER) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.796B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.568B | 15.40 |
| Cerus (CERS) | United States | $0.476B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.433B | 73.77 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Evolus (EOLS) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.235B | 138.00 |
| TerrAscend (TSNDF) | Canada | $0.228B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.32 |
| Sanara MedTech (SMTI) | United States | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.178B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.140B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.87 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.103B | 4.52 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.08 |
| Nephros (NEPH) | United States | $0.053B | 38.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 14.93 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |